The University of Maryland School of Medicine will begin testing its cell-based bird flu vaccine in January in preparation for a possible flu pandemic in the near future.

Researchers expect the cell-based vaccine that uses whole virus particles to provide immunity faster and more reliably than those incubated in chicken eggs then broken into fragments, according to a release from the university. This will be the first whole-virus vaccine for bird flu tested in the United States.